Skip to main content

IAF bids farewell to MiG-21 Bison aircraft, paving the way for India's indigenous fighter jets

To keep you updated, we send Defence News to your mailbox. In case, you wish to Unsubscribe Click Here
The Economic Times

Defence News


Dear Reader,

Just catching up? Here are the top defence stories from the day...
IAF bids farewell to MiG-21 Bison aircraft, paving the way for India's indigenous fighter jetsIAF bids farewell to MiG-21 Bison aircraft, paving the way for India's indigenous fighter jets
The MiG-21 Bison aircraft bid farewell in a historic ceremony in Rajasthan, marking the end of their service and the beginning of a new era for the Indian Air Force. These aging aircraft, serving for six decades, will be replaced by the indigenous Light Combat Aircraft (LCA) Mark-1A. The transition reflects the IAF's commitment to modernization and safety. Air Chief Marshal VR Chaudhary revealed plans to retire all MiG-21s by 2024. Read more
Israel army says intercepted 'missile' from Red Sea regionIsrael army says intercepted 'missile' from Red Sea region
The Israeli military said on Tuesday its forces intercepted a missile fired from the Red Sea region, as tensions surged across the Middle East amid Israel's war with Hamas in Gaza. "A surface-to-surface missile was fired toward Israeli territory from the area of the Red Sea and was successfully intercepted by the 'Arrow' aerial defence system," the military said in a statement. Read more
Northern Army Commander visits Ladakh, reviews border defence infrastructureNorthern Army Commander visits Ladakh, reviews border defence infrastructure
"The Army commander felicitated the troops of the Indian Army, ITBP and GREF for their relentless efforts in maintaining the highest standards of operational effectiveness under challenging conditions," the officials said. Read more
Scientists from China and Sri Lanka conduct joint "marine scientific" research onboard Chinese vesselScientists from China and Sri Lanka conduct joint "marine scientific" research onboard Chinese vessel
Scientists from China and Sri Lanka are collaborating on "marine scientific" activities aboard the Chinese research vessel 'Shi Yan 6' in Sri Lankan waters. Concerns were raised by India and the US about the vessel's presence, leading to a delay in granting permission by Sri Lanka. The research will focus on studying seawater temperature, sea wave conditions, their impact on fish, climate change, and various seawater levels. Read more
icon
Israeli forces battle Hamas around Gaza City, as military says 800,000 have fled southIsraeli forces battle Hamas around Gaza City, as military says 800,000 have fled south
More than half the territory's 2.3 million Palestinians have fled their homes, with hundreds of thousands sheltering in packed U.N.-run schools-turned-shelters or in hospitals alongside thousands of wounded patients. Israeli strikes have hit closer to several northern hospitals in recent days, alarming medics. Read more
US announces new nuclear bomb 24 times more powerful than one dropped on Japan: ReportUS announces new nuclear bomb 24 times more powerful than one dropped on Japan: Report
The US Department of Defense plans to develop the B61-13 nuclear gravity bomb, awaiting Congressional approval. This bomb, 24 times more powerful than the one used on Hiroshima in WW II, aims to address evolving security challenges. It won't increase the total nuclear stockpile. This decision aligns with a changing security landscape, with a focus on deterrence and alliance assurance, as stated by Assistant Secretary of Defense for Space Policy John Plumb. Read more
A UN envoy says the Israel-Hamas war is spilling into Syria, adding to growing instability thereA UN envoy says the Israel-Hamas war is spilling into Syria, adding to growing instability there
Geir Pedersen told the Security Council that, on top of violence from the Syrian conflict, the Syrian people now face "a terrifying prospect of a potential wider escalation" following Hamas' Oct. 7 attacks on Israel and the ongoing retaliatory military action. Read more
Israeli soldier freed in Gaza during ground operation, Israeli army saysIsraeli soldier freed in Gaza during ground operation, Israeli army says
The military said the soldier, who it identified as Ori Megidish, had been kidnapped by Hamas on Oct. 7. It said she had since undergone medical checks and was "doing well." Read more
Benjamin Netanyahu says Gaza ceasefire 'will not happen'Benjamin Netanyahu says Gaza ceasefire 'will not happen'
"Just as the United States would not agree to a ceasefire after the bombing of Pearl Harbor or after the terrorist attack of 9/11, Israel will not agree to a cessation of hostilities with Hamas after the horrific attacks of October 7," Benjamin Netanyahu said at a press conference with foreign journalists. Read more
Thanks for reading. Follow us on Twitter and Facebook.

Did you like today's newsletter?

hate it love it

Comments

Popular posts from this blog

The first drug for a common, deadly liver disease is here – and more are coming

VIEW IN BROWSER | SUBSCRIBE TUE, MAR 19, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good morning!  Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for the condition.    In a landmark decision on Thursday, the Food and Drug Administration approved Madrigal Pharmaceuticals ' drug " Rezdiffra ," to be used along with diet and exercise. The company expects the medicine to be available next month with a hefty price tag of $47,400 per year before insurance and other rebates.    So, why is this approval so important?    First of all, people suffering from the disease badly need a treatment. Rezdiffra is specifically approved to treat patients with nonalcoholic steatoh

J&J, Merck and Bristol Myers Squibb are in the hot seat

VIEW IN BROWSER | SUBSCRIBE TUE, JAN 30, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com .    Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks ahead.    CEOs from those companies are slated to testify at a Senate hearing on high prescription drug prices in the U.S. on Feb. 8 at 10 a.m. ET, Sen. Bernie Sanders announced Friday.   It took subpoena threats from the senator, but J&J CEO Joaquin Duato and Merck CEO Robert Davis have agreed to testify after both executives declined earlier requests to appear at the Senate HELP committee's hearing. They join Bristol Myers Squibb CEO Chris Boerner, who agr

How competitive can Roche be in the weight loss drug market?

VIEW IN BROWSER | SUBSCRIBE TUE, SEP 17, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon!  Roche is one of several drugmakers hoping to join the booming weight loss drug market, which Novo Nordisk and Eli Lilly are currently dominating. But can the Swiss company develop drugs that can compete with that duopoly?  The answer isn't clear yet.  We need to see more data from longer and larger clinical trials, which will likely take years for Roche to conduct.  But the company last week presented more early-stage data more early-stage data on its experimental obesity injection and pill, which some analysts said raised concerns about how competitive those products can be if they enter the space. Some analysts said the new results showed that both drugs – which Roche acquired through its nearly $3 billion acquisition of Carmot Therapeutics in December – caused a higher rate of side